Suchergebnisse - "Ito, Kentaro"

PubPharm (215)

1

Nintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis

enthalten in: Annals of the American Thoracic Society | 2024

von Ikeda, S. | Ogura, T. | Kato, T. | +14

2

Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis : Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)

enthalten in: Targeted oncology | 2024

von Nishioka, N. | Imai, H. | Endo, M. | +35

3

Linear dichroism reveals the perpendicular orientation of DNA bases in the RecA and Rad51 recombinase filaments : A possible mechanism for the strand exchange reaction

enthalten in: Chirality | 2024

von Takahashi, M. | Ito, K. | Iwasaki, H. | +1

4

Physical Activity Using a Wearable Device as an Alternative to Performance Status in Patients With Advanced Lung Cancer

enthalten in: JAMA oncology | 2024

von Ito, K. | Suzuki, Y. | Sakaguchi, T. | +5

5

Human Rad51 Protein Requires Higher Concentrations of Calcium Ions for D-Loop Formation than for Oligonucleotide Strand Exchange

enthalten in: International journal of molecular sciences | 2024

von Renodon-Corniere, A. | Mikawa, T. | Kuwabara, N. | +4

6

Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC : post hoc analysis from NEJ051

enthalten in: Scientific reports | 2024

von Miura, K. | Yamaguchi, O. | Mori, K. | +13

7

Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma

enthalten in: JTO clinical and research reports | 2024

von Hazama, D. | Nakahama, K. | Kodama, H. | +18

8

Impact of immune‐related adverse events on survival outcomes in extensive‐stage small cell lung cancer patients treated with immune checkpoint inhibitors

enthalten in: Cancer Medicine | 2024

von Nishimura, T. | Fujimoto, H. | Fujiwara, T. | +19

9

Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors

enthalten in: Cancer medicine | 2024

von Nishimura, T. | Fujimoto, H. | Fujiwara, T. | +19

10

Efficacy and safety of second-line therapy of docetaxel plus ramucirumab after first-line platinum-based chemotherapy plus immune checkpoint inhibitors in non-small cell lung cancer (SCORPION) : a multicenter, open-label, single-arm, phase 2 trial

enthalten in: EClinicalMedicine | 2023

von Matsuzawa, R. | Morise, M. | Ito, K. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]